Evidence map›Paper›PMID 41407422›Full record

ArticleBMJ open2025

Understanding barriers and enablers for vaccination against COVID-19 and influenza among healthcare workers: a mixed-methods study nested within the UK SIREN cohort.

Dominic Sparkes, Katie Munro, Atiya Kamal, Jack Haywood, Anna Howells, Sarah Foulkes, Sophie Russell, Naomi Platt, Jonathan Broad, Colin S Brown and 4 more

Abstract readMulticenter Study
In one paragraph

Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Dominic SparkesUKHSA, London, UK.ORCID http://orcid.org/0000-0002-8475-3864
Katie MunroUKHSA, London, UK.
Atiya KamalSchool of Social Sciences, Birmingham City University, Birmingham, UK.
Jack HaywoodUKHSA, London, UK.
Anna HowellsPublic Health Wales, Cardiff, UK.
Sarah FoulkesUKHSA, London, UK.
Sophie RussellUKHSA, London, UK.
Naomi PlattUKHSA, London, UK.
Jonathan BroadUKHSA, London, UK.
Colin S BrownUKHSA, London, UK.
Susan HopkinsUKHSA, London, UK.
Jasmin IslamSIREN Study Team, UK Health Security Agency, London, UK.
Victoria HallUKHSA, London, UK victoria.hall@ukhsa.gov.uk.
SIREN Study Team

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo investigate vaccination coverage for influenza and COVID-19 in the SARS-CoV-2 immunity and reinfection evaluation (SIREN) study cohort of healthcare workers (HCWs) between 2020 and 2023 and explore vaccination enablers and barriers.

designA mixed-methods study nested within SIREN, a multicentre prospective cohort study of HCWs across the UK. Quantitative and qualitative methods were used sequentially, using an expansion/explanation function, enabling emergent themes observed from the quantitative stage to be explored in the qualitative stage.

settingSIREN sites include secondary care centres and community mental health trusts in the UK.

participantsQuantitative analysis was conducted on data from 6048 participants. Participants were representative of the HCW workforce, with the majority being women (83%) and of white ethnicity (88%). Nurses made up the largest occupational group (33%). Qualitative analysis of data from 24 participants including five focus groups (n=21) and three semistructured interviews (n=3); 82% women, 26% minority ethnic, all working age from across the UK. PRIMARY OUTCOME MEASURES: Quantitative: vaccine coverage for COVID-19 and influenza vaccines by demographic with multivariable logistical regression used to assess differences. Qualitative: thematic analysis to explore reasons behind the results seen in the quantitative stage.

resultsCOVID-19 vaccination was initially high; 97% received two doses and 94% a first booster. However, coverage was reduced to 77%, for the second booster. Influenza vaccination coverage was lowest in 2020-2021 (46%), increasing to 73% in 2021-2022 and to 79% in 2022-2023. In 2022-2023, vaccination coverage was higher for influenza than for COVID-19. High vaccine coverage for both COVID-19 and influenza was observed in doctors, pharmacists and therapists. Porters, healthcare assistants and staff from minority ethnic groups had lower vaccine coverage for both COVID-19 and influenza. Four themes were identified: (1) attitudes towards vaccination changed throughout the COVID-19 pandemic; (2) HCWs used data to inform vaccination decisions; (3) poor communication in healthcare settings contributed to a reduction in vaccination; (4) there were both positive and negative impacts of the COVID-19 vaccine on influenza vaccine uptake and other vaccination programmes.

conclusionsBetween 2020 and 2023 in our cohort, COVID-19 vaccination coverage decreased, whereas influenza increased. Our study found attitudes to both vaccines have shifted, becoming more favourable to influenza and less to COVID-19 boosters. Barriers to COVID-19 boosters, including concerns about side effects and vaccine effectiveness, need to be addressed with improved communication on the benefits and adverse events. Future vaccination strategies should address the differences we have identified in vaccine coverage across demographics and occupational groups, including continued efforts to improve vaccine equity. TRIAL REGISTRATION NUMBER: ISRCTN11041050.

Indexed as

COVID-19COVID-19 VaccinesHealth PersonnelInfluenza, HumanInfluenza VaccinesVaccinationVaccination CoverageAdultAttitude of Health PersonnelFemaleHumansMaleMiddle AgedProspective StudiesQualitative ResearchSARS-CoV-2COVID-19 VaccinesInfluenza VaccinesCOVID-19VaccinationVIROLOGY

Identifiers

PMID41407422
PMCPMC12716576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.